With the deadline for Bain Capital and Cinven’s second attempt for German pharmaceuticals manufacturer Stada coming, and going, on Wednesday at midnight the 63% approval threshold looks poised to again sunder the deal, unless a late surge in tenders is announced on Friday.
↧